Ribonucleotide reductase drugs for Sickle Cell Disease

3 tracked Ribonucleotide reductase drugs in the Sickle Cell Disease race. The class explanation lives on the Ribonucleotide reductase page; the full indication pipeline across every mechanism is on the Sickle Cell Disease page.

3 approved / phase 4

Head-to-head evidence: Hydroxyurea (Droxia) vs Hydroxyurea (Xromi) · Hydroxyurea (Siklos) vs Hydroxyurea (Xromi)

The roster

← all Ribonucleotide reductase drugs